Reckitt Benckiser LLC

Quick facts

Marketed products

• Mucinex® · Respiratory
  Guaifenesin reduces mucus viscosity and promotes clearance of respiratory secretions by increasing hydration of mucus in the airways.

Phase 3 pipeline

• Nurofen Plus® · Pain Management
  Nurofen Plus combines ibuprofen (a nonsteroidal anti-inflammatory drug) with codeine phosphate (an opioid analgesic) to provide enhanced pain relief through dual analgesic and anti-inflammatory action.
• Panadeine® Extra · Pain management
  Panadeine Extra contains paracetamol and codeine, which work together to relieve pain and reduce fever.

Phase 2 pipeline

• Immediate-release Guaifenesin · Respiratory
  Guaifenesin is an expectorant that works by increasing the volume and reducing the viscosity of respiratory tract secretions.

Phase 1 pipeline

• Children's Mucinex® Grape Flavor
• Humibid®
• Humibid® and Hydrocodone Bitartrate tablet

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Reckitt Benckiser LLC portfolio CI brief
• Reckitt Benckiser LLC pipeline updates RSS